X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-05 | ANTX | Day Lucy | CFO | S - Sale | $1.01 | -8,807 | 75,363 | -10% | -$8,883 | |||||
| M | 2026-01-05 | ANTX | Prior Stephen David | Chief Strategy Officer | S - Sale | $1.01 | -6,462 | 59,086 | -10% | -$6,507 | |||||
| M | 2026-01-05 | ANTX | Chanda Sanjay | Chief Development Officer | S - Sale | $1.01 | -9,251 | 75,823 | -11% | -$9,332 | |||||
| M | 2026-01-05 | ANTX | Eizen Joshua M | See Remarks | S - Sale | $1.00 | -24,854 | 152,499 | -14% | -$24,962 | |||||
2025-11-04 | ANTX | Eizen Joshua M | See Remarks | S - Sale | $1.14 | -2,819 | 177,353 | -2% | -$3,214 | ||||||
2025-11-04 | ANTX | Prior Stephen David | Chief Strategy Officer | S - Sale | $1.14 | -765 | 65,548 | -1% | -$872 | ||||||
2025-05-28 | ANTX | Leonard Braden Michael | 10% | S - Sale | $1.09 | -200,000 | 3,017,432 | -6% | -$218,000 | ||||||
2025-06-02 | ANTX | Easom Eric | CEO | P - Purchase | $1.07 | +10,000 | 1,516,262 | +1% | +$10,665 | ||||||
| M | 2025-05-28 | ANTX | Leonard Braden Michael | 10% | S - Sale | $1.13 | -2,532,000 | 3,217,432 | -44% | -$2,872,477 | |||||
2025-05-28 | ANTX | Fitzpatrick Margaret M | Dir | P - Purchase | $1.18 | +8,610 | 8,610 | New | +$10,133 | ||||||
2025-01-03 | ANTX | Day Lucy | CFO | S - Sale | $1.34 | -2,957 | 32,670 | -8% | -$3,965 | ||||||
2025-01-03 | ANTX | Chanda Sanjay | Chief Development Officer | S - Sale | $1.34 | -2,957 | 29,824 | -9% | -$3,965 | ||||||
2025-01-03 | ANTX | Prior Stephen David | Chief Strategy Officer | S - Sale | $1.34 | -2,029 | 33,313 | -6% | -$2,721 | ||||||
2025-01-03 | ANTX | Eizen Joshua M | See Remarks | S - Sale | $1.34 | -9,663 | 116,672 | -8% | -$12,958 | ||||||
| M | 2024-12-06 | ANTX | Readnour Robin Shane | Dir | P - Purchase | $1.45 | +60,000 | 652,573 | +10% | +$86,708 | |||||
| M | 2024-11-26 | ANTX | Readnour Robin Shane | Dir | P - Purchase | $1.41 | +75,000 | 622,573 | +14% | +$105,685 | |||||
2024-11-27 | ANTX | Zakrzewski Joseph S | Dir | P - Purchase | $1.40 | +2,000 | 531,079 | 0% | +$2,800 | ||||||
| M | 2024-11-19 | ANTX | Readnour Robin Shane | Dir | P - Purchase | $1.07 | +200,000 | 514,788 | +64% | +$213,128 | |||||
| M | 2024-11-18 | ANTX | Zakrzewski Joseph S | Dir | P - Purchase | $1.00 | +25,000 | 529,079 | +5% | +$25,046 | |||||
2024-11-18 | ANTX | Easom Eric | CEO | P - Purchase | $1.00 | +50,000 | 1,361,012 | +4% | +$49,970 | ||||||
2024-08-14 | ANTX | Leonard Braden Michael | 10% | P - Purchase | $1.04 | +1,500,000 | 5,749,432 | +35% | +$1,560,000 | ||||||
2024-08-09 | ANTX | Ra Capital Management, L.P. | 10% | S - Sale | $1.08 | -3,525,094 | 300,853 | -92% | -$3,807,102 | ||||||
2024-01-18 | ANTX | Zakrzewski Joseph S | Dir | S - Sale | $19.11 | -100,000 | 504,079 | -17% | -$1,911,410 | ||||||
2024-01-16 | ANTX | Aziz Kabeer | Dir | S - Sale | $19.65 | -100,000 | 2,373,500 | -4% | -$1,965,000 | ||||||
2024-01-16 | ANTX | Adjuvant Global Health Technology Fund, L.P. | 10% | S - Sale | $19.65 | -100,000 | 2,373,500 | -4% | -$1,965,000 | ||||||
2024-01-12 | ANTX | Readnour Robin Shane | Dir | S - Sale | $21.92 | -1,425 | 485,073 | 0% | -$31,229 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |